Argentina vs Cameroon: New cases tested for RR-/MDR-TB
Argentina
56.0%
in 2024
Cameroon
50.0%
in 2024
Argentina rank
158th
Cameroon rank
161st
New cases tested for RR-/MDR-TB over time
- Argentina
- Cameroon
How they compare
Argentina currently reports 56.0% against 50.0% in Cameroon, a difference of 6.0%.
That makes Argentina's figure about 1.1 times Cameroon's.
The two have swapped places 4 times across 11 shared years of data; in 2013 it was Argentina ahead.
Argentina ranks 158th and Cameroon ranks 161st of 192 countries.
Argentina has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Argentina | Cameroon | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 20.4% | 13.4% | 7.1% | Argentina |
| 2020s | 44.5% | 37.0% | 7.5% | Argentina |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher new cases tested for rr-/mdr-tb, Argentina or Cameroon?
- Argentina, at 56.0% against 50.0% in Cameroon as of 2024.
- What is the difference in new cases tested for rr-/mdr-tb between Argentina and Cameroon?
- 6.0%, with Argentina ahead.
- How many years of comparable data are there for Argentina and Cameroon?
- 11 years are reported by both, from 2013 to 2024.
- How do Argentina and Cameroon rank globally for new cases tested for rr-/mdr-tb?
- Argentina ranks 158th and Cameroon ranks 161st of 192 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as New cases tested for RR-/MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.